Difficulties in Kawasaki Disease Diagnosis and Treatment in Children
https://doi.org/10.21508/1027-4065-2020-65-6-122-128
Abstract
The Kawasaki disease is the acute vasculitis specific to the childhood that affects the medium-sized arteries and causes the coronary aneurysms in about 25% of the patients untreated. This disease is one of the causes of the heart diseases acquired in the children in the economically developed countries. The cause of the Kawasaki disease remains unknown. The Article is based on the current guidelines and clinical case, with special focus on the necessity of the early diagnosis and proper treatment, since only early diagnosis and timely treatment of the patients with this disease prevent the damage of the coronary arteries.
About the Authors
A. E. Dobrovanov
A. Getlik Clinic for Children and Adolescents, Slovak Medical University and University Hospital; St. Elizabeth University of Health and Social Sciences; National Pirogov Memorial Medical University
Slovakia
Slovakia
Oleksandr Dobrovanov - MBA – Masterof Business Administration
Bratislava
Vinnytsya
D. Dmytriev
National Pirogov Memorial Medical University; Department of Anesthesiology, Intensive Care Unit and Pain Medicine, Vinnytsya Regional Clinical Endocrinology Center
Ukraine
Dmytro DmytriievVinnytsya
Ukraine
Dmytro DmytriievVinnytsya
K. Yu. Dmytrieva
National Pirogov Memorial Medical University
Ukraine
Ukraine
Dmytriieva Kateryna
Vinnytsya
L. Hustavova
Slovak Medical University, 1st Department of Surgery, Faculty of Medicine, SMU and UNB, Children's Hospital
Slovakia
Lucia Hustavova - PhD
Bratislava
Slovakia
Lucia Hustavova - PhD
Bratislava
References
1. Majerova L., Olejnik P., Vrsanska V. Diagnosis and treatment of Kawasaki disease in children and its coronary complications. Pediatr Prax 2018; 19(5): 224–228.
2. McCrindle B.W., Rowley A.H., Newburger J.W., Burns A.F., Bolger M.G., Annette L.B. et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association [online]. Circulation 2017; 135: e927–e999. DOI: 10.1161/CIR.0000000000000484
3. Геппе Н.А., Подчерняева Н.С., Лыскина Г.А. Руководство по детской ревматологии. М.: ГЭОТАР-Медиа, 2011; 720. [Geppe N.A., Podchernjaeva N.S., Lyskina G.A. Guidelines for Pediatric Rheumatology. Moscow: GEOTAR-Media, 2011; 720. (in Russ.)]
4. Lyskina G.A., Shirinskaya O.G. Clinical manifestation, diagnostics and treatment of Kawasaki disease: known data and unsolved questions. Voprosy sovremennoi pediatrii (Current Pediatrics) 2013; 12(1): 63–73.
5. Baker A.L., Lu M., Minich L.L., Atz A.M., Klein G.L., Korsin R. et al. Associated symptoms in the ten days before diagnosis of Kawasaki disease. J Pediatr 2009; 154: 592–595.
6. Verdoni L., Mazza A., Gervasoni A., Martelli L., Ruggeri M., Ciuffreda M. et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020; 395(10239): 1771–1778. DOI: https://doi.org/10.1016/S0140-6736(20)31103-X
7. Scheinfeld N.S., Jones E.L., Ogershok P.R., Parrillo S.J. Kawasaki disease [online]. Diseases Conditions. 2017; https://emedicine.medscape.com/article/965367-overview#a5
8. Gedalia A. Kawasaki disease: 40 years after the original report [online]. Curr Rheumatol Rep 2007; 9(4): 336–341. DOI: 10.1007/s11926-007-0053-7
9. Newburger J.W., Takahashi M., Gerber M.A., Lloyd Y.T., Jane C.B., Stanford T. et al. Diagnosis, treatment, and longterm management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110: 2747–2771. DOI: 10.1161/01.CIR.0000145143.19711.78
10. Lin K.H., Chang S.S., Yu C.W., Lin S.C., Liu S.C., Chao H.I. et al. Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: A systematic review and meta-analysis [online]. BMJ Open 2015; 5: 1. DOI: 10.1136/bmjopen-2014-006703
11. Margossian R., Lu M., Minich L.L., Bradley T.J., Cohen M.S., Li J.S., et al. Pediatric Heart Network Investigators. Predictors of coronary artery visualization in Kawasaki disease. J Am Soc Echocardiogr 2011; 24: 53–59. DOI: 10.1016/j.echo.2010.10.015
12. Olejnik P., Boruta P., Glezlova A., Bordacova L., Masura J. The first experiences with the high-resolution multi-slice CT-angiography in pediatric cardiology in Slovakia. Bratisl Med J 2008; 109(5): 220–223
13. Kardos M., Olejnik P., Culen M., Masura J. Indication criteria for cardiac CT and MRI in patients with congenital heart defects. Kardiol Prax 2013; 11(4): 185–189.
14. Olejnik P., Berecova Z., Boruta P., Masura J. Selected chapters from pediatric cardiology: MRI in pediatric cardiology [online]. 1st edition. Bratislava: Univerzita Komenskeho, 2015; 177.
15. http://www.fmed.uniba.sk/fileadmin/lf/sluzby/akademicka_kniznica/PDF/Elektronicke_knihy_LF_UK/MRI_v_detskej_kardiologii.pdf
16. Olejnik P., Berecova Z., Boruta P., Masura J. Selected chapters from pediatric cardiology: CT-angiography in pediatric cardiology [online].1st edition. Bratislava: Univerzita Komenskeho, 2012; 156.
17. https://www.fmed.uniba.sk/fileadmin/lf/sluzby/akademicka_kniznica/PDF/Elektronicke_knihy_LF_UK/CT_-_angiografia_v_detskej_kardiologii.pdf
18. Харченко Г.А., Кимирилова Г.О. Клинико-эпидемиологическая характеристика кори в Астраханской области в период 2013–2019 гг. Российский вестник перинатологии и педиатрии 2020; 65(1): 86–93. [Kharchenko G.A., Kimirilova O.G. Clinical and epidemiological characteristics of measles in the Astrakhan region in 2013–2019. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2020; 65(1): 86–93. (in Russ).] DOI: 10.21508/1027-4065-2020-65-1-86-93
19. Mori M., Miyamae T., Imagawa T., Katakura S., Kimura K., Yokota S. Meta-analysis of the results of intravenous gamma globulin treatment of coronary artery lesions in Kawasaki disease. Mod Rheumatol 2004; 14: 361–366. DOI: 10.1007/s10165-004-0324-3
20. Oates-Whitehead R.M., Baumer J.H., Haines L., Love S., Maconochie I.K., Gupta A., et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 2003; 4: CD004000. DOI: 10.1002/14651858.CD004000
21. Dobrovanov O., Kralinsky K., Kovalchuk VP. Etiological agents of urinary infections and microbial resistance: retrospective study. Lek Obzor (Bratislava) 2019; 68(7): 186–190.
22. Kralinsky K., Kmecova L., Dobrovanov O. Nová éra antimikrobiálnej terapie. Abstrakty prednášok. 50. celoslovenská pediatrická konferencia s medzinárodnou účasťou Galandové dni. Pediatria (Bratislava) 2018; S3/13: 12–13.
23. Dobrovanov O., Kralinsky K., Krcmery V. Start of the respiratory infection season and initial antibiotic therapy. Pediatria (Bratislava) 2018; 13(5): 245–250.
Review
For citations:
Dobrovanov A.E., Dmytriev D., Dmytrieva K.Yu., Hustavova L. Difficulties in Kawasaki Disease Diagnosis and Treatment in Children. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2020;65(6):122-128. (In Russ.) https://doi.org/10.21508/1027-4065-2020-65-6-122-128
Views: 915
_.jpg)
.png)
Email this article 